EMR vs IR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 06, 2026

EMR

59.8
AI Score
VS
EMR Wins

IR

54.1
AI Score

Investment Advisor Scores

EMR

60score
Recommendation
BUY

IR

54score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR IR Winner
Forward P/E 20.4918 18.9394 IR
PEG Ratio 1.7016 0.6052 IR
Revenue Growth 7.0% 8.5% IR
Earnings Growth 23.0% 6.5% EMR
Tradestie Score 59.8/100 54.1/100 EMR
Profit Margin 13.8% 12.1% EMR
Beta 1.00 1.00 Tie
AI Recommendation BUY STRONG BUY IR

Relative Price Performance (Last 90 Days)

EMR 1M: -2.6% · 3M: +10.6% IR 1M: -13.5% · 3M: +5.7%

Current Technical Phase

EMR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $152.82

IR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.1 · Price: $76.36

Fundamentals Snapshot

Metric EMR IR
Market Cap
Forward P/E 21.1 19.5
Trailing P/E 32.9 30.9
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.3% 0.2%
EPS 4.57 2.44
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.